On this episode of Stock Movers:


- Ryanair signaled robust demand for travel this summer, with fares rising and Europeans sticking close to home for their holidays.


- Diageo expects sales growth to improve in the second half of the year and set out a cost-cutting program, as the British distiller grapples with US tariffs on its shipments from the UK and Europe.


- Shares in drug companies Roche and BioArctic may be active in Monday trading after US drug regulators approved the first blood test to help diagnose Alzheimer’s disease, potentially making it easier to find and treat patients.

On this episode of Stock Movers:
 - Ryanair signaled robust demand for travel this summer, with fares rising and Europeans sticking close to home for their holidays.
 - Diageo expects sales growth to improve in the second half of the year and set out a cost-cutting program, as the British distiller grapples with US tariffs on its shipments from the UK and Europe.
 - Shares in drug companies Roche and BioArctic may be active in Monday trading after US drug regulators approved the first blood test to help diagnose Alzheimer&rsquo;s disease, potentially making it easier to find and treat patients.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

Ryanair Up, Diageo's Tariff Losses, Roche Up

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/d8ebe232-c646-4a41-97ba-b2e20089ad1c/transcript